White Paper

Digital Patient Engagement and Improved Biosimilar Adoption Outcomes in Specialty Pharmacy

Cassian Solutions · January 30, 2024 · 1 min read

Download PDF (opens in a new tab)
Cassian Solutions Inc. logo.
Lumicera Health Services logo.

Let's delve into the groundbreaking insights from our newly published white paper, "Digital Patient Engagement and Improved Biosimilar Adoption Outcomes in Specialty Pharmacy". This comprehensive study, conducted in partnership with Lumicera Health Services, explores the transformative power of digital patient engagement in the realm of specialty pharmacy.

The white paper presents an enlightening comparison between traditional call-center methods and innovative digital engagement strategies. Our findings reveal a notable surge in patient conversion rates and substantial cost savings when digital methods are employed. This emphasizes the critical role of technology in enhancing patient care and streamlining operations in specialty pharmacies.

As we navigate the evolving landscape of healthcare, this study underscores the importance of integrating digital solutions for better patient outcomes and operational efficiency. Dive into our white paper for an in-depth understanding of how digital patient engagement is reshaping the future of biosimilar adoption in specialty pharmacy. Don't miss out on these pivotal insights!

Download the whitepaper here:

Keep reading.

SOC 2 Type IIHIPAA21 CFR Part 11GDPRAnnex 11

Established 2018-Trusted by leading specialty pharmacy-600+ medications supported

One conversation to see how your programs would run on ONE Journey™.

See ONE Journey™
in ACTION

Request a Demo